Achilles Therapeutics PLC (ACHL)
0.91
+0.01
(+1.53%)
USD |
NASDAQ |
May 24, 16:00
0.89
-0.02
(-2.20%)
After-Hours: 20:00
Achilles Therapeutics Total Assets (Quarterly): 145.74M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 145.74M |
| December 31, 2023 | 161.46M |
| September 30, 2023 | 175.34M |
| June 30, 2023 | 197.91M |
| March 31, 2023 | 207.64M |
| December 31, 2022 | 220.36M |
| September 30, 2022 | 227.35M |
| Date | Value |
|---|---|
| June 30, 2022 | 257.72M |
| March 31, 2022 | 292.19M |
| December 31, 2021 | 317.11M |
| September 30, 2021 | 330.00M |
| June 30, 2021 | 353.49M |
| March 31, 2021 | 206.10M |
| December 31, 2020 | 218.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
145.74M
Minimum
Mar 2024
353.49M
Maximum
Jun 2021
236.52M
Average
219.64M
Median
Total Assets (Quarterly) Benchmarks
| Barinthus Biotherapeutics PLC | 199.48M |
| TC BioPharm (Holdings) PLC | 9.171M |
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.39M |
| Shareholders Equity (Quarterly) | 130.35M |